93 related articles for article (PubMed ID: 23141520)
1. The influence of dexamethasone administration on the protection against doxorubicin-induced cardiotoxicity in purified embryonic stem cell-derived cardiomyocytes.
Dehghani L; Farokhpour M; Karbalaie K; Nematollahi M; Tanhaie S; Hayati-Rodbari N; Kiani-Esfahani A; Hescheler J; Nasr-Esfahani MH; Baharvand H
Tissue Cell; 2013 Apr; 45(2):101-6. PubMed ID: 23141520
[TBL] [Abstract][Full Text] [Related]
2. Embryonic stem cell-derived cardiomyocytes as a model system to study cardioprotective effects of dexamethasone in doxorubicin cardiotoxicity.
Farokhpour M; Karbalaie K; Tanhaei S; Nematollahi M; Etebari M; Sadeghi HM; Nasr-Esfahani MH; Baharvand H
Toxicol In Vitro; 2009 Oct; 23(7):1422-8. PubMed ID: 19596060
[TBL] [Abstract][Full Text] [Related]
3. Effects of oxytocin on cardiomyocyte differentiation from mouse embryonic stem cells.
Hatami L; Valojerdi MR; Mowla SJ
Int J Cardiol; 2007 Apr; 117(1):80-9. PubMed ID: 17034884
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow stromal cells as an inducer for cardiomyocyte differentiation from mouse embryonic stem cells.
Yue F; Johkura K; Tomotsune D; Shirasawa S; Yokoyama T; Nagai M; Sasaki K
Ann Anat; 2010 Sep; 192(5):314-21. PubMed ID: 20801009
[TBL] [Abstract][Full Text] [Related]
5. A novel purification method of murine embryonic stem cell- and human-induced pluripotent stem cell-derived cardiomyocytes by simple manual dissociation.
Shinozawa T; Furukawa H; Sato E; Takami K
J Biomol Screen; 2012 Jun; 17(5):683-91. PubMed ID: 22274911
[TBL] [Abstract][Full Text] [Related]
6. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach.
Sartiani L; Bettiol E; Stillitano F; Mugelli A; Cerbai E; Jaconi ME
Stem Cells; 2007 May; 25(5):1136-44. PubMed ID: 17255522
[TBL] [Abstract][Full Text] [Related]
7. Exogenous treatment with eicosapentaenoic acid supports maturation of cardiomyocytes derived from embryonic stem cells.
Shabani P; Ghazizadeh Z; Pahlavan S; Hashemizadeh S; Baharvand H; Aghdami N; Doosti M
Biochem Biophys Res Commun; 2015 May; 461(2):281-6. PubMed ID: 25871791
[TBL] [Abstract][Full Text] [Related]
8. The influence of the time interval between monoHER and doxorubicin administration on the protection against doxorubicin-induced cardiotoxicity in mice.
Bruynzeel AM; Mul PP; Berkhof J; Bast A; Niessen HW; van der Vijgh WJ
Cancer Chemother Pharmacol; 2006 Nov; 58(5):699-702. PubMed ID: 16565833
[TBL] [Abstract][Full Text] [Related]
9. Effect of basic fibroblast growth factor on cardiomyocyte differentiation from mouse embryonic stem cells.
Khezri S; Valojerdi MR; Sepehri H; Baharvand H
Saudi Med J; 2007 Feb; 28(2):181-6. PubMed ID: 17268693
[TBL] [Abstract][Full Text] [Related]
10. High glucose suppresses embryonic stem cell differentiation into cardiomyocytes : High glucose inhibits ES cell cardiogenesis.
Yang P; Chen X; Kaushal S; Reece EA; Yang P
Stem Cell Res Ther; 2016 Dec; 7(1):187. PubMed ID: 27938398
[TBL] [Abstract][Full Text] [Related]
11. The effect of cyclic strain on embryonic stem cell-derived cardiomyocytes.
Gwak SJ; Bhang SH; Kim IK; Kim SS; Cho SW; Jeon O; Yoo KJ; Putnam AJ; Kim BS
Biomaterials; 2008 Mar; 29(7):844-56. PubMed ID: 18022225
[TBL] [Abstract][Full Text] [Related]
12. Differentiation-dependent doxorubicin toxicity on H9c2 cardiomyoblasts.
Branco AF; Sampaio SF; Moreira AC; Holy J; Wallace KB; Baldeiras I; Oliveira PJ; Sardão VA
Cardiovasc Toxicol; 2012 Dec; 12(4):326-40. PubMed ID: 22744233
[TBL] [Abstract][Full Text] [Related]
13. Pitx2c modulates cardiac-specific transcription factors networks in differentiating cardiomyocytes from murine embryonic stem cells.
Lozano-Velasco E; Chinchilla A; Martínez-Fernández S; Hernández-Torres F; Navarro F; Lyons GE; Franco D; Aránega AE
Cells Tissues Organs; 2011; 194(5):349-62. PubMed ID: 21389672
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological characteristics of embryonic stem cell-derived cardiomyocytes are cell line-dependent.
Hannes T; Wolff M; Doss MX; Pfannkuche K; Haustein M; Müller-Ehmsen J; Sachinidis A; Hescheler J; Khalil M; Halbach M
Cell Physiol Biochem; 2015; 35(1):305-14. PubMed ID: 25591772
[TBL] [Abstract][Full Text] [Related]
15. Proteome profiling of mouse embryonic stem cells to define markers for cell differentiation and embryotoxicity.
Osman AM; van Dartel DA; Zwart E; Blokland M; Pennings JL; Piersma AH
Reprod Toxicol; 2010 Sep; 30(2):322-32. PubMed ID: 20553848
[TBL] [Abstract][Full Text] [Related]
16. Enhanced toxicity and ROS generation by doxorubicin in primary cultures of cardiomyocytes from neonatal metallothionein-I/II null mice.
Fu Z; Guo J; Jing L; Li R; Zhang T; Peng S
Toxicol In Vitro; 2010 Sep; 24(6):1584-91. PubMed ID: 20600803
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of functional murine embryonic stem cell-derived cardiomyocytes and comparison with adult heart: profiling of murine ESC-derived cardiomyocytes.
Shinozawa T; Tsuji A; Imahashi K; Nakashima K; Sawada H; Toyoshiba H; Yamamoto S; Takami K; Imai R
J Biomol Screen; 2009 Mar; 14(3):239-45. PubMed ID: 19211779
[TBL] [Abstract][Full Text] [Related]
18. Effect of bone morphogenetic protein-4 on cardiac differentiation from mouse embryonic stem cells in serum-free and low-serum media.
Taha MF; Valojerdi MR
Int J Cardiol; 2008 Jun; 127(1):78-87. PubMed ID: 17714812
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural comparison of developing mouse embryonic stem cell- and in vivo-derived cardiomyocytes.
Baharvand H; Piryaei A; Rohani R; Taei A; Heidari MH; Hosseini A
Cell Biol Int; 2006 Oct; 30(10):800-7. PubMed ID: 16877013
[TBL] [Abstract][Full Text] [Related]
20. Biological pacemakers: characterization in an in vitro coculture model.
Hannes T; Halbach M; Nazzal R; Frenzel L; Saric T; Khalil M; Hescheler J; Brockmeier K; Pillekamp F
J Electrocardiol; 2008; 41(6):562-6. PubMed ID: 18790503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
